Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
H.P. Acthar Gel
Pharma
Bankruptcy cleared way for Mallinckrodt's $260M settlement
Mallinckrodt has agreed to a $260 million settlement to resolve claims that it underpaid Medicaid rebates and violated an anti-kickback statute.
Kevin Dunleavy
Mar 8, 2022 4:39pm
Congressional hearing Thursday to address drug price reforms
Dec 6, 2021 10:39am
Mallinckrodt faces federal prosecutors in Acthar rebate lawsuit
Mar 3, 2020 4:25pm
Mallinckrodt looks to 'modernized' Acthar post-opioid settlement
Feb 25, 2020 4:04pm
Mallinckrodt floats $1.6B opioid deal, generics bankruptcy
Feb 24, 2020 5:38pm
Mallinckrodt unloads its CDMO for $250M as potential liabilities mount
Sep 10, 2019 10:34am
